QTC-85594-26729

4 vaccinations 6 coded responses 28 check-ins 5 free-text entries 4 call cases

Sex: Female
Age at first dose: 36-40
ZIP prefix: 532 / WI
Registered: 2021-03-27

Relationship: Self
Race: White
Ethnicity: N/A

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-05
Dose 1 — Pfizer-BioNTech
2021-03-26
Dose 2 — Pfizer-BioNTech
2021-03-27
Registered in v-safe
2021-03-27
Health check-in — days 1–6 daily, dose 2
Feeling: Poor · Site: Pain · Fever · Fatigue or tiredness, Rash, not including the immediate area around the injection site · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Adult check-in
2021-03-27
Report sent to call center — days 1–6 daily, dose 2
Get care from a doctor or other healthcare professional

1 call case(s)
2021-03-28
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Fatigue or tiredness

Adult check-in
2021-03-29
Survey response — days 1–6 daily, dose 2
MedDRA: Injection site bruising — Feeling: Good · Site: Pain

Free text: Bruising around injection site

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-30
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-04-01
Survey response — days 1–6 daily, dose 2
MedDRA: Feeling abnormal — Feeling: Fair · Fatigue or tiredness

Free text: Brain fog

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-02
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-04-09
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-04-16
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-04-23
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-04-30
Health check-in — day 35, dose 2
Feeling: Fair

Adult check-in
2021-05-07
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-06-27
Survey response — 3 months, dose 2
MedDRA: Adverse reaction, Pre-existing disease — Feeling: Good

Free text: Possibly a flare up of my multifocal choroiditis. Would need to see my specialist to confirm.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-09-24
Survey response — 6 months, dose 2
MedDRA: Condition aggravated, Pre-existing disease — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Flare up my posterior uveitis.

MedDRA releases: 2024-11 · check-in free text available
2021-09-24
Report sent to call center — 6 months, dose 2
Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2021-09-27
Call 1 — Could Not Reach Participant
2021-10-04
Call 2 — Could Not Reach Participant
2021-10-28
Dose 3 — Pfizer-BioNTech
2022-03-26
Survey response — 12 months, dose 2
MedDRA: Condition aggravated, Polycystic ovarian syndrome, Pre-existing disease, Urticaria — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Diagnosed with PCOS Broke out in hives several times Several flares of of preexisting posterior uveitis

MedDRA releases: 2024-11 · check-in free text available
2022-03-26
Report sent to call center — 12 months, dose 2
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-03-29
Call successful
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
2022-03-29
Call successful
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
2022-03-29
Call successful
Not applicable (accidental reporting or does not believe symptoms are related to vaccine)
2022-09-27
Dose 4 — Pfizer-BioNTech
2022-09-28
Health check-in — days 1–6 daily, dose 4
Feeling: Fair · Site: Pain · Fatigue or tiredness, Diarrhea · Be unable to work or attend school

Adult check-in
2022-09-29
Health check-in — days 1–6 daily, dose 4
Feeling: Good · Site: Pain · Fatigue or tiredness

Adult check-in
2022-09-30
Health check-in — days 1–6 daily, dose 4
Feeling: Good · Site: Pain · Rash, not including the immediate area around the injection site

Adult check-in
2022-10-01
Health check-in — days 1–6 daily, dose 4
Feeling: Good · Site: Pain · None

Adult check-in
2022-10-02
Health check-in — days 1–6 daily, dose 4
Feeling: Fair · Site: Pain · Fever · Chills, Diarrhea

Adult check-in
2022-10-03
Health check-in — days 1–6 daily, dose 4
Feeling: Fair · Fatigue or tiredness

Adult check-in
2022-10-04
Health check-in — day 7, dose 4
Feeling: Good · None

Adult check-in
2022-10-11
Health check-in — day 14, dose 4
Feeling: Fair

Adult check-in
2022-10-18
Health check-in — day 21, dose 4
Feeling: Fair

Adult check-in
2022-10-25
Health check-in — day 28, dose 4
Feeling: Good

Adult check-in
2022-11-01
Health check-in — day 35, dose 4
Feeling: Good

Adult check-in
2022-11-08
Health check-in — day 42, dose 4
Feeling: Good

Adult check-in
2022-12-27
Health check-in — 3 months, dose 4
Feeling: Fair

Adult check-in
2023-03-30
Survey response — 6 months, dose 4
MedDRA: Cyst, Gastrointestinal disorder — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

MedDRA releases: 2024-11
2023-03-30
Report sent to call center — 6 months, dose 4
Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2023-03-31
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-05	Pfizer-BioNTech
2	2021-03-26	Pfizer-BioNTech
3	2021-10-28	Pfizer-BioNTech	No
4	2022-09-27	Pfizer-BioNTech	No

Call center

4 call center cases

3 successful · 1 unsuccessful

See the call center timeline

Free text

Release 6 — days 1–6 daily, dose 2

2021-03-29

Systemic reaction (other): Bruising around injection site

2021-04-01

Systemic reaction (other): Brain fog

Release 9 — 3 months, dose 2

2021-06-27

Symptoms: Possibly a flare up of my multifocal choroiditis. Would need to see my specialist to confirm.

Release 9 — 6 months, dose 2

2021-09-24

Symptoms: Flare up my posterior uveitis.

Release 11 — 12 months, dose 2

2022-03-26

Symptoms: Diagnosed with PCOS Broke out in hives several times Several flares of of preexisting posterior uveitis

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Adverse reaction	✓	✓	✓
SD	Condition aggravated	·	·	✓
SD	Cyst	·	·	✓
SD	Gastrointestinal disorder	·	·	✓
SD	Polycystic ovarian syndrome	·	·	✓
SD	Pre-existing disease	✓	✓	✓
SD	Urticaria	·	·	✓
SRO	Feeling abnormal	✓	✓	✓
SRO	Injection site bruising	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release